Medications for Pain Management Flashcards

1
Q

fentanyl citrate (Sublimaze)

A

A NARCOTIC ANALGESIC, schedule II, that binds to opiate receptors producing analgesia and euphoria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

fentanyl citrate (Sublimaze) Indications

A

Treatment of hemodynamically STABLE patients with moderate to severe pain due to traumatic or medical conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

fentanyl citrate (Sublimaze) Contraindications

A

Hemodynamic instability
Shock
Respiratory Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

fentanyl citrate (Sublimaze) Dosage and Administration

A

1-2 mcg/kg. May be repeated after 5 minutes and titrated to clinical effect to a max dose of 300 mcg.

Intranasal: 1-2 mcg/kg. May be repeated after 5 minutes for a max dose of 300 mcg.
IV route is preferred for repeat dosing.
Additional analgesia requires base contact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

fentanyl citrate (Sublimaze) Pediatric Dosage and Administration

A

1-2 mcg/kg. May be repeated after 5 minutes and titrated to clinical effect. Max dose of 3 mcg/kg.
Additional dosing : Contact Base.

Intranasal: 2 mcg/kg. May be repeated after 10 minutes to a max dose of 4 mcg/kg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

fentanyl citrate (Sublimaze) Special Considerations

A

Do not administer more than 1 mL per nostril.
100 times more potent than morphine and is less likely to cause a histamine response.
The goal is to make the pain tolerable enough to allow for adequate assessment, treatment, and transportation.
Respiratory depression, including apnea, may occur suddenly without warning. Start with half the traditional dose in children or the elderly.
Chest wall rigidity has been reported with rapid administration of fentanyl.

Pregnancy Class C.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ketamine (Ketalar)

A

A general anesthetic, ANALGESIC, and sedative that is a non-competitive NMDA receptor antagonist and dissociative.

Onset - 1-5 minutes after IM administration.
Duration - 10-15 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ketamine (Ketalar) Indications

A

If fentanyl is contraindicated
Opiate dependence in acute pain

NOT TO BE USED FOR SEDATION.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ketamine (Ketalar) Contraindications

A

Known allergy
Relative contraindication in patients with known cardiovascular disease because it can cause tachycardia.
Altered mental status
Kids less than 18 and adults over 65.
Known history of severe behavioral disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ketamine (Ketalar) Dosage and Administration

A

0.3 mg/kg IV in 50 mL of D5W or NS over 5 minutes - typically 20-30 mg

0.5 mg/kg IM/IN - typically 30-50 mg

The typical duration of action is 20 minutes. May repeat after 20 minutes for a total of 2 doses.
Contact base for additional analgesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ketamine (Ketalar) Special Considerations

A

May provoke hyper-salivation, typically controlled by suctioning (not usually seen at the analgesic dose).
May cause hallucinations, euphoria, and dysphoria.
Potential increase in heart rate and blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Topical Ophthalmic Anestehetics

A

proparacaine and tetracaine are local anesthetics approved for ocular administration for relief of eye pain caused by corneal abrasion or chemical injury.

Indications: Pain secondary to eye injuries and corneal abrasions.
Topical anesthetic to facilitate eye irrigation.

Contraindications: Known allergies to local anesthetics and globe lacerations or rupture.

Precautions: Transient burning/stinging when initially applied.

Dosage and administration: 2 drops into the affected eye. Contact base for repeat dosing.

Special considerations:
Transient burning/ stinging when initially applied.
Single patient use. Unused portions should be discarded, only new bottles may be used.
Do not administer until patient consents to transport and transport has begun - TRANSPORT IS REQUIRED.
Topical ophthalmic anesthetics should never be given to a patient for self-administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ketorolac (Toradol)

A

An NSAID that inhibits the production of prostaglandins in inflamed tissue, which decreases the responsiveness of pain receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ketorolac (Toradol) Indications

A

Moderately severe acute pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ketorolac (Toradol) Adverse Effects

A

Headache
Drowsiness
Dizziness
Abdominal Pain
Dyspepsia
Nausea/vomiting
Diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ketorolac (Toradol) Contraindications

A

Pregnancy or breast feeding
History of GI bleeding or active stomach ulcer.
History of chronic kidney disease or transplant.
Anticoagulation/Antiplatelet (blood thinners) or history of a blood clotting disorder.
Multisystem Trauma.
Acute head trauma or suspected intracranial bleed.
Patients less than 12 years old and over 65 years old.
Severe dehydration.

Pregnancy class C; class D during thrid trimester.

17
Q

ketorolac (Toradol) Dosage and Administration

A

15 mg IV or IM

Not indicated for pediatrics.

18
Q

morphine sulfate

A

An OPIATE AGONIST, schedule C-II, that binds with opioid receptors. Reduces simulation of the sympathetic nervous system caused by pain and anxiety.

19
Q

morphine sulfate Indications

A

Treatment of hemodynamically STABLE patients with moderate to severe pain due to traumatic or medical conditions.

20
Q

morphine sulfate Contraindications

A

Hypotension
Hemodynamic instability
Shock

21
Q

morphine sulfate Dosage and Administration

A

Adult: 5-10 mg IV/IM. Dose may be repeated after 10 minutes and titrated to clinical effect. Max dose of 10 mg. Additional dosing requires base contact.

Pediatric: 0.1 mg/kg. Max single dose of 6 mg. The dose may be repeated after 10 minutes and titrated to clinical effect up to max cumulative dose of 0.2 mg/kg or 10 mg.
Less than 1 year = Contact base.

22
Q

morphine sulfate Special Considerations

A

Should not be given IN, as it is poorly absorbed.
Should only be given to hemodynamically stable patients and titrated slowly to effect.
The goal is to make the patient’s pain tolerable enough to allow for adequate assessment, treatment, and transport.
Respiratory depression, including apnea, may occur suddenly without warning and is more common in children and the elderly. Start with half the traditional dose in children and the elderly.
Coadministration of opioids and benzodiazepines is discouraged and may only be done with a direct physician verbal order.

Pregnancy Class C.